Diabetes UK's research strategy 2025-2030
Diabetes research is entering a golden era, and our 2025–2030 Research Strategy sets out how we’ll harness this momentum to transform lives.
Building on major achievements our research has helped make possible – from delivering type 2 diabetes remission programmes to emerging type 1 diabetes immunotherapies – we’re stepping up our efforts where they’re most urgently needed.
We’ve co-created this strategy with people living with, affected by, and working in diabetes, including people from underserved communities who are most impacted.
It lays out four key research priority areas that will help us drive progress where it’s needed most.
- Pursuing cures
- Prevention and early detection
- Personalised and accessible care
- Supporting wellbeing
We need researchers and funders to help us embrace this moment of scientific opportunity and make major advances that benefit everyone at risk of and living with all types of diabetes, regardless of background, identity, geography or income.
UK strategy for clinical and applied diabetes research
Diabetes UK and the National Institute for Health and Care Research (NIHR) have developed a joint strategy to inform the direction of clinical and applied diabetes research in the UK. It is designed to help the UK diabetes research community collaborate in areas with the most need and greatest promise, to foster research that improves care and speeds up progress towards new treatments.
The strategy is a product of discussions across England, Scotland, Northern Ireland and Wales involving groups of experts, people with diabetes, researchers and clinicians, and represents the results of a comprehensive analysis of diabetes research funding across the UK during 2014-2019.
Read the UK strategy for clinical and applied diabetes research.
